SleepWell Trade

Trend-Following Backtester · Guide · backtest 한국어

equity · US

Altimmune, Inc. backtest

10 trend-following strategies were compared on the full daily history of Altimmune, Inc.. 10 beat buy-and-hold CAGR; ADX / DI 방향성 ranks first by Sharpe, matching the main backtester. The return/drawdown alternative is ADX / DI 방향성 (CAGR 34.7%, MDD -55.0%).

Data 2017-05-26 ~ 2026-07-31daily bars 2,307 (9.2 years)Costs 0.5%Venue XNASMonthly snapshot 2026-07-31

Results by strategy

10 of 10 beat buy and hold (CAGR -34.3%, drawdown -98.9%).

Sharpe leader (same as main): ADX / DI 방향성 — CAGR 34.7%, MDD -55.0%, Sharpe 0.88, 11% exposure.

Return/drawdown alternative: ADX / DI 방향성 — CAGR is 69.0%p higher than buy and hold, while drawdown improves by 43.9%p (CAGR 34.7%, MDD -55.0%, exposure 11%).

The alternative must retain 75% of buy-and-hold CAGR, improve drawdown by at least 20% and 5 percentage points, and stay below 95% exposure; the ranking weights return retention 60% and drawdown improvement 40%.

Strategy · parametersCAGRMDDSharpeCalmarTotalTradesExposure
ADX / DI 방향성
period=38, threshold=22
34.7%-55.0%0.880.6315.4x1011%
Keltner 채널 돌파
emaPeriod=46, atrPeriod=9, mult=4
25.6%-63.0%0.720.418.1x811%
볼린저 밴드 돌파
n=41, k=3.3
18.5%-85.4%0.580.224.8x1612%
SMA 크로스오버
fast=40, slow=66
10.4%-92.0%0.490.112.5x3432%
Supertrend
period=12, mult=3.6
4.5%-82.6%0.430.051.5x3732%
ROC 모멘텀
n=68, threshold=0.06
2.5%-86.5%0.400.031.3x9228%
EMA 크로스오버
fast=12, slow=80
2.7%-85.8%0.360.031.3x2624%
Donchian 채널 돌파
entryN=35, exitN=20
-4.5%-94.5%0.34-0.050.7x2827%
Parabolic SAR
step=0.045, maxStep=0.36
-11.6%-90.8%0.24-0.130.3x27542%
MACD
fast=8, slow=58, signal=7
-22.1%-95.1%0.17-0.230.1x18553%
Buy and hold-34.3%-98.9%0.24-0.350.0x1100%
0.1 1x 10x 2018 2020 2022 2024 2026 ADX / DI 방향성Buy and hold
ADX / DI 방향성: Solid strategy line versus dashed buy-and-hold line. Log scale.
0% -25% -49% -74% -99% 2018 2020 2022 2024 2026 Buy and holdADX / DI 방향성
ADX / DI 방향성 maximum drawdown -55.0% (2020-07-20 → 2020-09-21), recovered after 731 days.

Rules of the top strategy

Looks at both the direction and the strength of the trend; holds only in a strong uptrend.

Method and caveats

Past performance does not guarantee future returns. Parameters were selected on the same full-history sample using sharpe over 40 trials per strategy, so results contain in-sample bias. 0.5% trading costs are included; taxes, slippage and rejected orders are not.
Re-run the same setupMore US assetsAll asset reports

Read next